Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02550990
Other study ID # 104-4892A3
Secondary ID
Status Recruiting
Phase N/A
First received September 6, 2015
Last updated December 19, 2016
Start date September 2015

Study information

Verified date December 2016
Source Chang Gung Memorial Hospital
Contact Ching-Yi Wu, ScD
Phone +886-3-2118800
Email cywu@mail.cgu.edu.tw
Is FDA regulated No
Health authority Taiwan: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the treatment effects of sequential combination of aerobic exercise and cognitive training on cognitive function, physiological markers, daily function, physical function, social participation and quality of life in stroke patients with cognitive decline. The investigators hypothesized that: (1) sequential training protocol can improve outcome measures compared to single mode of training; (2) these treatment effects will retain at 6-month follow-up.


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date
Est. primary completion date August 2018
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria:

1. Ischemic or hemorrhagic stroke occurring at least 6 months prior to enrollment

2. Age range from 20 to 90 years

3. MMSE score = 19

4. MoCA<26

5. Self- or informant-reported memory or cognitive complaints or CDR scale = 0.5

6. Able to follow the study instruction

7. Adequate cardiopulmonary function to perform aerobic exercise

8. Able to walk with or without assistive devices

Exclusion Criteria:

1. Unstable medical history (e.g., recent myocardial infarction) that might limit participation

2. Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)

3. Current participation in another interventional trial

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive training

Aerobic exercise training

Sequential combination of aerobic exercise and cognitive training


Locations

Country Name City State
Taiwan Chiayi Chang Gung Memorial Hospital Chiayi City
Taiwan Kaohsiung Chang Gung Memorial Hospital Kaohsiung City
Taiwan Keeling Chang Gung Memorial Hospital Keelung City
Taiwan Chang Gung Memorial Hospital Kwei-Shan Taoyuan
Taiwan Taipei Chang Gung Memorial Hospital Taipei City
Taiwan Taoyuan Chang Gung Memorial Hospital Taoyuan City

Sponsors (1)

Lead Sponsor Collaborator
Chang Gung Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change scores of Montreal Cognitive Assessment (MoCA) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Primary Change scores of Wechsler Memory Scale - Third Edition (WMS-III) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Primary Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Primary Change scores of Useful Field of View (UFOV) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Primary Change scores of Stroop Color-Word test Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Primary Change scores of Dual-task test The dual-task tests will be assessed to determine the ability for an individual to perform 2 tasks simultaneously. The investigators will assess the dual-task performance during walking and performing box and block test. The results of the dual-task tests will provide information regarding to whether the 2 tasks compete for the same class of neural resources or one of the tasks can be carried out automatically. Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of serum BDNF level Baseline, posttest (an expected average of 3 months) No
Secondary Change scores of Antioxidative marker Antioxidative markers will be used to reflect the changes on oxidative stress. In particular, we will be analyzing the total antioxidant capacity (TAC). Baseline, posttest (an expected average of 3 months) No
Secondary Change scores of Glucose indicator HbA1C level will be tested to investigate the relationships between blood glucose level and aerobic exercise. Baseline, posttest (an expected average of 3 months) No
Secondary Change scores of Plasma lipid level The cholesterol ratio (total cholesterol divided by high-density lipid) will be evaluated to reflect the lipid level in the blood. Baseline, posttest (an expected average of 3 months) No
Secondary Change scores of Functional Independence Measure (FIM) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Lawton Instrumental Activities of Daily Living Scale (Lawton IADL) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Stroke Impact Scale (SIS) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Caregiver Burden (CB) scale Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of EuroQol (EQ)-5D questionnaire Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Timed up and go test (TUG) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Six-minute walk test (6MWT) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Mobility level Baseline, posttest (an expected average of 3 months) No
Secondary Change scores of International Physical Activity Questionnaires (IPAQ) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Fugl-Meyer Assessment (FMA) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Rivermead Mobility Index (RMI) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of muscle strength We will evaluate isometric knee flexors and extensors muscle strength using handheld dynamometer. Also, we will use hand dynamometer to measure grip strength of the affected and less affected hand while the participant is seated, with the elbow at 90-degree flexion. We will record the mean value of 3 attempts. Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Community Integration Questionnaire (CIQ) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Change scores of Geriatric Depression Scale (GDS) Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months) No
Secondary Genotyping of the BDNF val66met polymorphism Between baseline and posttest (an expected average of 3 months) No
See also
  Status Clinical Trial Phase
Completed NCT03045991 - Effects and Mechanism of the Sequential Combination of Exercise and Cognitive Training in Stroke Patients N/A
Completed NCT03230253 - Effects and Mechanism of Two Hybrid Exercise-cognitive Trainings in Mild Ischemic Stroke With Cognitive Decline N/A